<p>PBMCs from one donor were electroporated using 1SM buffer, 20 µg of pT3-20z plasmid and 0,5 µg of SB100x transposase plasmid. One day later, lymphocytes were stimulated with irradiated L388 cells and CAR expression was evaluated until d+30 by flow cytometry analysis using an anti-fab antibody. (A) Representative histograms of 20z CAR expression at d+1, d+10, d+20 and d+30 after electroporation (gray line = non electroporated cells stained anti-Fab; black line = lymphocytes electroporated with pT3-20z). (B) Analysis of 20z CAR expression until d+30 summarizing data of <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0060298#pone-0060298-g008" target="_blank">Figure 8A</a>. (C) Kinetics of expansion of control mock ele...
2019-04-19Adoptive transfer of chimeric antigen receptor (CAR) engineered T cells is an emerging can...
<p>(<b>A</b>) PBMCs from two healthy donors were electroporated using in house buffers and 4 µg of p...
© 2016 Dr Alexander DavenportDespite the success of autologous chimeric antigen receptor (CAR) T cel...
Chimeric antigen receptors (CARs) have been used extensively in adoptive immunotherapy to modify T l...
Abstract: Chimeric antigen receptors (CARs) have been used extensively in adoptive immunotherapy to ...
Immunotherapy is becoming recognized as a superior treatment for cancer. In recent years, chimeric a...
Abstract Background Effective gene-delivery systems for primary human T cell engineering are useful ...
Immunotherapy utilizing chimeric antigen receptor (CAR) T cells is a promising strategy for the trea...
Recently approved by the FDA and European Medicines Agency, CAR-T cell therapy is a new treatment op...
Chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of cancer is now an approved ...
Chimeric antigen receptor (CAR) T-cells are genetically engineered to express a synthetic receptor w...
<p>(a) SupT1 were electroporated with or without 20 µg mRNA encoding the indicated TcR_2A. Twelve ho...
<p>Left-hand panel: MM cell lines were electroporated with an expression vector for EGFP (pEGFP-N3; ...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
CAR T cell therapy represents a promising method in treatment of hematological malignancies. Gene im...
2019-04-19Adoptive transfer of chimeric antigen receptor (CAR) engineered T cells is an emerging can...
<p>(<b>A</b>) PBMCs from two healthy donors were electroporated using in house buffers and 4 µg of p...
© 2016 Dr Alexander DavenportDespite the success of autologous chimeric antigen receptor (CAR) T cel...
Chimeric antigen receptors (CARs) have been used extensively in adoptive immunotherapy to modify T l...
Abstract: Chimeric antigen receptors (CARs) have been used extensively in adoptive immunotherapy to ...
Immunotherapy is becoming recognized as a superior treatment for cancer. In recent years, chimeric a...
Abstract Background Effective gene-delivery systems for primary human T cell engineering are useful ...
Immunotherapy utilizing chimeric antigen receptor (CAR) T cells is a promising strategy for the trea...
Recently approved by the FDA and European Medicines Agency, CAR-T cell therapy is a new treatment op...
Chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of cancer is now an approved ...
Chimeric antigen receptor (CAR) T-cells are genetically engineered to express a synthetic receptor w...
<p>(a) SupT1 were electroporated with or without 20 µg mRNA encoding the indicated TcR_2A. Twelve ho...
<p>Left-hand panel: MM cell lines were electroporated with an expression vector for EGFP (pEGFP-N3; ...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
CAR T cell therapy represents a promising method in treatment of hematological malignancies. Gene im...
2019-04-19Adoptive transfer of chimeric antigen receptor (CAR) engineered T cells is an emerging can...
<p>(<b>A</b>) PBMCs from two healthy donors were electroporated using in house buffers and 4 µg of p...
© 2016 Dr Alexander DavenportDespite the success of autologous chimeric antigen receptor (CAR) T cel...